《大行報告》美銀證券降中國金茂(00817.HK)評級至「中性」 私有化金茂酒店乏良好財務回報潛力
美銀證券發表研報指,中國金茂(00817.HK)以逾30%溢價私有化金茂酒店(06139.HK),背後缺乏良好的財務回報潛力和足夠的商業理由,加上2020財年業務或有大部分來自一次性收益,業績前景不明朗,因此將金茂的評級由「買入」下調至「中性」。
美銀又指,預期是次私有化交易將拖累金茂盈利的1%至2%,並影響淨負債率約5%,但相信金茂擁有融資優勢,合約銷售增長亦較同業快,下行空間不大,維持目標價6.3元不變,較每股資產淨值預測折讓35%。(gc/u)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.